vimarsana.com
Home
Live Updates
Suven Life Sciences : October 30, 2023Suven Life Sciences announces Positive Topline Results from a Phase-2 study evaluating Samelisant -October 30, 2023 at 06:31 am EDT : vimarsana.com
Suven Life Sciences : October 30, 2023Suven Life Sciences announces Positive Topline Results from a Phase-2 study evaluating Samelisant -October 30, 2023 at 06:31 am EDT : vimarsana.com
Suven Life Sciences : October 30, 2023Suven Life Sciences announces Positive Topline Results from a Phase-2 study evaluating Samelisant -October 30, 2023 at 06:31 am EDT
CSD/BSE&NSE/PR/2023-2024
October 30, 2023
To
...
Related Keywords
Washington ,
United States ,
Bandra ,
Maharashtra ,
India ,
Mumbai ,
Canada ,
Hyderabad ,
Andhra Pradesh ,
Telangana ,
Venkat Jasti ,
Shrenik Soni ,
Society For Neuroscience ,
Exchange Plaza ,
Us Food Drug Administration ,
Suven Life Sciences ,
Drug Discovery Development ,
Listing Department ,
Department Of Corporate Services ,
National Stock Exchange Of India ,
Corporate Services ,
Stock Exchange ,
India Limited ,
Bandra Kurla Complex ,
News Release ,
Life Sciences ,
Positive Topline Results ,
Excessive Daytime Sleepiness ,
Hillsi Hyderabad ,
Epworth Sleepiness Scale ,
Drug Administration ,
Central Nervous System ,
Clinical Global Impression ,
Patient Global Impression Change ,
Suven Life ,
Ramakrishna Nirogi ,
Vice President ,
Drug Discovery ,
Wakefulness Test ,
Major Depressive Disorder ,
Attention Deficient Hyperactivity Disorder ,
Markets ,